Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Gastrointestinal Stromal Tumors 17 Sarcoma 6 Sarcoma, Ewing 5 Osteosarcoma 5 Neoplasm Metastasis 4 Rhabdomyosarcoma 3 Colorectal Neoplasms 3 Mesothelioma, Malignant 2 Hemangiosarcoma 2 Chondrosarcoma 2 Bone Neoplasms 2 Wilms Tumor 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Tertiary Lymphoid Structures 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Piebaldism 1 Patient Compliance 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Melanoma 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1

Interventions

regorafenib 1 Curettage 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Chondroma × regorafenib × Sarcoma × Clear all

NCT02389244 2025-09-16

REGOBONE

UNICANCER

Phase 2 Active not recruiting

Chondroma, Chondrosarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡